These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37467634)

  • 1. Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma.
    Zhao L; Wang Z; Xu Y; Zhang P; Qiu J; Nie D; Wu G; Chen C; Chang Y; Xia Q
    Pathol Res Pract; 2023 Aug; 248():154641. PubMed ID: 37467634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
    Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
    Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
    J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma.
    Wang L; Wang J; Zhao H; Jiang G; Feng X; Sui W; Liu H
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):551-563. PubMed ID: 30607469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of HDAC10 as a candidate oncogene in clear cell renal carcinoma that facilitates tumor proliferation and metastasis.
    Yang L; Wei Q; Chen X; Yang Y; Huang Q; Wang B; Ma X
    Diagn Pathol; 2024 Sep; 19(1):120. PubMed ID: 39237939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and prognostic significance of fatty acid synthase in clear cell renal cell carcinoma.
    Yuan Y; Yang X; Li Y; Liu Q; Wu F; Qu H; Gao H; Ge J; Xu Y; Wang H; Wang Y; Zhao Z
    Pathol Res Pract; 2020 Nov; 216(11):153227. PubMed ID: 33027752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway.
    Lv Q; Wang G; Zhang Y; Han X; Li H; Le W; Zhang M; Ma C; Wang P; Ding Q
    Int J Oncol; 2019 Apr; 54(4):1221-1232. PubMed ID: 30968158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
    Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
    Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
    Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
    Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RUNX2 interacts with SCD1 and activates Wnt/β-catenin signaling pathway to promote the progression of clear cell renal cell carcinoma.
    Song X; Liu J; Liu B; Piao C; Kong C; Li Z
    Cancer Med; 2023 Mar; 12(5):5764-5780. PubMed ID: 36200301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Expression of ADAP2 is Associated With Aggressive Behavior of Human Clear-Cell Renal Cell Carcinoma and Poor Patient Survival.
    Qiang Y; Wang X; Ding J; Wang Z; Li B; Ji H; Zhang X; Yang Y; Liu K; Zhang L; Ma S; Zhao D; Lu G
    Clin Genitourin Cancer; 2023 Apr; 21(2):e78-e91. PubMed ID: 36127253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SIRT5 functions as a tumor suppressor in renal cell carcinoma by reversing the Warburg effect.
    Yihan L; Xiaojing W; Ao L; Chuanjie Z; Haofei W; Yan S; Hongchao H
    J Transl Med; 2021 Dec; 19(1):521. PubMed ID: 34930316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
    Huang S; Hou Y; Hu M; Hu J; Liu X
    BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formin-related protein 1 facilitates proliferation and aggressive phenotype of clear cell renal cell carcinoma through MAPK/MMP2 pathway.
    Ma G; Zhang B; Fu S; Lu J; Zhang L; Shang P; Yue Z
    Mol Cell Probes; 2023 Oct; 71():101921. PubMed ID: 37454877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
    Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
    Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
    Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
    Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK/MAPK Signalling Pathway Regulates MMP2 through ETS1 in Renal Clear Cell Carcinoma.
    Chen HB; Li W; Yang Z; Liu KL; Lu BS; Wang ZY
    Curr Mol Med; 2024; 24(6):780-789. PubMed ID: 37254537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
    Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J
    Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gallic acid suppresses the progression of clear cell renal cell carcinoma through inducing autophagy via the PI3K/Akt/Atg16L1 signaling pathway.
    Zhang T; Zhang X; Fei Y; Lu J; Zhou D; Zhang L; Fan S; Zhou J; Liang C; Su Y
    Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38818827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.